Premium
Pharmacogenetics: optimising prescribing in primary care
Author(s) -
Youssef Essra,
Thornley Tracey,
Guchelaar HenkJan,
Wright David J
Publication year - 2022
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1982
Subject(s) - pharmacogenetics , medicine , primary care , genetic testing , drug reaction , adverse effect , intensive care medicine , drug , family medicine , pharmacology , genotype , biochemistry , chemistry , gene
Pharmacogenetic (PGx) testing to personalise prescribing of certain medicines can improve patient outcomes and reduce adverse drug reactions. This article summarises the key findings of the PGx Impact study, designed to estimate the impact of pre‐emptive genetic testing on prescribing, and discusses potential ways in which pharmacogenetic testing may optimise primary care prescribing in the near future.